These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2903657)

  • 21. Efficacy of celiprolol in hypertension and angina pectoris. Introduction.
    Norris RJ
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1195-6. PubMed ID: 1672600
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction.
    Dorow P; Clauzel AM; Capone P; Mayol R; Mathieu M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S102-4. PubMed ID: 2427835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celiprolol in hypertension.
    Taylor SH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1426-34. PubMed ID: 2903654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol.
    Jackson NC; Lee PS; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S145-7. PubMed ID: 2427846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
    Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celiprolol in the treatment of exercise induced angina pectoris.
    Capone P; Mayol R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S135-7. PubMed ID: 2427844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of celiprolol and propranolol in the treatment of hypertension in one hundred and seventy-nine subjects.
    Leary P; Mayol R; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():70-2. PubMed ID: 2864068
    [No Abstract]   [Full Text] [Related]  

  • 32. Celiprolol--review of airways studies.
    Dorow P
    Am J Cardiol; 1988 Feb; 61(5):23C-26C. PubMed ID: 2963522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo-controlled double-blind multicenter study of celiprolol in the treatment of mild and moderate hypertension.
    Capone P; Mayol R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S119-21. PubMed ID: 2427840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
    Matthys H; Doshan HD; Rühle KH; Applin WJ; Braig H; Pohl M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S40-2. PubMed ID: 2427851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoneutral effects in hypertensive asthmatics--celiprolol versus chlorthalidone.
    Dorow P
    J Int Med Res; 1988; 16 Suppl 1():23A-26A. PubMed ID: 2975609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical pharmacology of celiprolol: a cardioselective beta-adrenergic antagonist and mild vasodilator.
    Perrone MH; Barrett JA
    Am Heart J; 1991 Feb; 121(2 Pt 2):677-83. PubMed ID: 1671187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
    Cleophas TJ; vd Mey N; Meulen J; Niemeyer MG
    Am J Ther; 1997 Apr; 4(4):117-22. PubMed ID: 10423600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualities of an ideal beta-adrenoceptor antagonist and comparison of existing agents with a new cardioselective hydrophilic vasodilator beta-adrenoceptor antagonist, celiprolol.
    Opie LH
    Am J Cardiol; 1988 Feb; 61(5):8C-13C. PubMed ID: 2893535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celiprolol in systemic hypertension.
    Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
    Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.